Loss of tissue nonspecific alkaline phosphatase (TNAP) 56 or receptor-activity-modifying-protein-1 (RAMP1) 67 expression markedly increase neutrophil infiltration and tissue damage in AP, thus maintaining their expression may be a therapeutic strategy. Here, RAMP1 is linked to alkaline phosphatase measurement.